These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37667195)

  • 21. COVID-19 vaccine acceptance rate and its predictors in Ethiopia: A systematic review and meta-analysis.
    Belay GM; Alemu TG; Techane MA; Wubneh CA; Assimamaw NT; Tamir TT; Muhye AB; Kassie DG; Wondim A; Terefe B; Tarekegn BT; Ali MS; Fentie B; Gonete AT; Tekeba B; Kassa SF; Desta BK; Ayele AD; Dessie MT; Atalell KA
    Hum Vaccin Immunother; 2022 Nov; 18(6):2114699. PubMed ID: 36094824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis.
    Liang Y; Sun Q; Liu Q; Pang Y; Tang S
    Front Public Health; 2023; 11():1044788. PubMed ID: 37900041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pooled rates and demographics of POTS following SARS-CoV-2 infection versus COVID-19 vaccination: Systematic review and meta-analysis.
    Yong SJ; Halim A; Liu S; Halim M; Alshehri AA; Alshahrani MA; Alshahrani MM; Alfaraj AH; Alburaiky LM; Khamis F; Muzaheed ; AlShehail BM; Alfaresi M; Al Azmi R; Albayat H; Al Kaabi NA; Alhajri M; Al Amri KAS; Alsalman J; Algosaibi SA; Al Fares MA; Almanaa TN; Almutawif YA; Mohapatra RK; Rabaan AA
    Auton Neurosci; 2023 Dec; 250():103132. PubMed ID: 38000119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 vaccine breakthrough infections in Virginia, January 17, 2021 - June 30, 2021.
    Darby B; Alexander V; Murphy J
    Vaccine; 2023 Feb; 41(7):1295-1298. PubMed ID: 36690560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis.
    Watanabe A; Kani R; Iwagami M; Takagi H; Yasuhara J; Kuno T
    JAMA Pediatr; 2023 Apr; 177(4):384-394. PubMed ID: 36689319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study.
    Moscara L; Venerito V; Martinelli A; Di Lorenzo A; Toro F; Violante F; Tafuri S; Stefanizzi P
    Vaccine; 2023 Aug; 41(38):5655-5661. PubMed ID: 37544827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study.
    Nelli F; Fabbri A; Virtuoso A; Giannarelli D; Giron Berrios JR; Marrucci E; Fiore C; Schirripa M; Signorelli C; Chilelli MG; Primi F; Pessina G; Natoni F; Silvestri MA; Ruggeri EM
    Curr Oncol; 2023 May; 30(5):5103-5115. PubMed ID: 37232844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease: A Systematic Review and Meta-analysis.
    Chen JJ; Lee TH; Tian YC; Lee CC; Fan PC; Chang CH
    JAMA Netw Open; 2021 Oct; 4(10):e2131749. PubMed ID: 34709385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
    Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.
    Plumb ID; Fette LM; Tjaden AH; Feldstein L; Saydah S; Ahmed A; Link-Gelles R; Wierzba TF; Berry AA; Friedman-Klabanoff D; Larsen MP; Runyon MS; Ward LM; Santos RP; Ward J; Weintraub WS; Edelstein S; Uschner D
    Vaccine; 2023 Apr; 41(15):2596-2604. PubMed ID: 36932031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults.
    Nishimi K; Neylan TC; Bertenthal D; Seal KH; O'Donovan A
    JAMA Netw Open; 2022 Apr; 5(4):e227287. PubMed ID: 35420660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors Associated with Vaccine Breakthrough Incidence among Health Care Workers Vaccinated with Inactivated SARS-CoV2 Vaccine (CoronaVac).
    Anshory M; Wahono CS; Pratama MZ; Rahman PA; Nugraha AS; Sekarani A
    J Res Health Sci; 2022 Jun; 22(2):e00551. PubMed ID: 36511263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.
    Mok CKP; Chen C; Zhao S; Sun Y; Yiu K; Chan TO; Lai HL; Lai KC; Lau KM; Ling KC; Chan KKP; Ng SS; Ko FW; Peiris M; Hui DS
    Lancet Microbe; 2023 Jun; 4(6):e418-e430. PubMed ID: 37086735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of cancer on the severity of disease in patients affected with COVID-19: an umbrella review and meta-meta-analysis of systematic reviews and meta-analyses involving 1,064,476 participants.
    Arayici ME; Basbinar Y; Ellidokuz H
    Clin Exp Med; 2023 Oct; 23(6):2221-2229. PubMed ID: 36207550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.
    Stouten V; Hubin P; Haarhuis F; van Loenhout JAF; Billuart M; Brondeel R; Braeye T; Van Oyen H; Wyndham-Thomas C; Catteau L
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis.
    Rahmani K; Shavaleh R; Forouhi M; Disfani HF; Kamandi M; Oskooi RK; Foogerdi M; Soltani M; Rahchamani M; Mohaddespour M; Dianatinasab M
    Front Public Health; 2022; 10():873596. PubMed ID: 36091533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients.
    Vanlerberghe B; Vrij C; Bogaerts K; Vermeersch P; Lagrou K; Molenberghs G; Rega F; Ceulemans LJ; van Raemdonck D; Jochmans I; Monbaliu D; Pirenne J; Vanuytsel T; Gillard P; Schoemans H; Cleemput JV; Kuypers D; Vos R; Nevens F; Verbeek J
    J Med Virol; 2023 Apr; 95(4):e28736. PubMed ID: 37185854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
    Tenforde MW; Patel MM; Ginde AA; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Gaglani M; McNeal T; Ghamande S; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Gershengorn HB; Babcock HM; Kwon JH; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Olson SM; Stephenson M; Schrag SJ; Kobayashi M; Verani JR; Self WH;
    Clin Infect Dis; 2022 May; 74(9):1515-1524. PubMed ID: 34358310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-COVID syndrome prevalence: a systematic review and meta-analysis.
    Sk Abd Razak R; Ismail A; Abdul Aziz AF; Suddin LS; Azzeri A; Sha'ari NI
    BMC Public Health; 2024 Jul; 24(1):1785. PubMed ID: 38965510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.